PatenSee ^{For Profit}

PatenSee is a clinical-stage startup company that has developed a contactless imaging device for the early detection of vascular access complications in hemodialysis patients. The company's technology uses a unique data stream to mimic a best practice physical examination. PatenSee's system is faster and non-contact, and it provides objective, AI learning analyses and reports. The company recently signed a clinical collaboration agreement with Fresenius Medical Care, following the completion of a POC clinical trial with very promising results. PatenSee is a portfolio company of MEDX Xelerator, a medical device incubator backed by Boston Scientific, Sheba Medical Center, MEDX Ventures Group, Consensus Business Group (CBG), West Pharmaceuticals, and The Portland Trust. Contact info: Address: 8 Ariel Sharon St. Or Yehuda, 6037606. Israel Email: N/APhone: +972-72-251-3566